DeepCura vs Sully.ai (2026)
Two agent suites that stopped being scribes some time ago, and both should be evaluated on what they do after the note. DeepCura runs eight named agents covering pre visit history, documentation, diagnosis mapping, allergy reconciliation, order generation and billing, with per field write back and the most complete published pricing ladder in this category. Sully sells role based agents for reception, scribing, coding, intake, triage and interpretation across the major record systems, publishes genuine technical work, and prices a bundle at a modest per provider rate. The uncomfortable common ground is autonomy: both draft orders and codes, both act on the record, and neither publishes a confidence threshold, an escalation path or an accuracy figure for any of it. Pilot them on how often a clinician edits what the agents produced, not on how many agents there are.
- The full per seat volume ladder is published, which is the most complete commercial disclosure located anywhere in this category, so a practice can price the whole platform before speaking to anyone.
- The architecture is eight named agents with defined scopes and per field write back, which is a clearer account of what each part does than a single assistant claim.
- A business associate agreement is offered to all covered entities rather than gated behind a tier, and the deployment question is answered by name rather than left open.
- The role based framing covers the whole encounter, reception through coding and triage, integrated with the major record systems, so one vendor spans the front desk and the exam room.
- It publishes real technical work rather than adjectives, including a benchmark result that is unflattering to its own category.
- A public trust center lists its security, privacy and AI governance documentation in one place, so procurement knows exactly what to request.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. DeepCura and Sully.ai are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | DeepCura | Sully.ai |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2023 | Not recorded |
| Headquarters | Not recorded | San Francisco, California, United States |
| Website | deepcura.com | sully.ai |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Sully.ai
-
Safety / governance
Sully published how it evaluates its AI clinical notes.
Source -
Product / capability
Sully.ai released an AI scribe specifically designed for nursing shifts, expanding its capabilities beyond standard physician visit documentation.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
DeepCura is an all in one clinical automation platform built around eight named agents rather than a single scribe: pre visit history, ambient documentation, diagnosis mapping to ICD-10 and SNOMED, allergy reconciliation, order generation covering labs, imaging, durable medical equipment and prescriptions, billing with CPT codes linked to diagnoses, referrals including prior authorization, and follow up scheduling, alongside a 24/7 AI receptionist, patient intake and a unified fax, email, phone and SMS hub.
Source: AI Health Index, August 2026
Sully.ai sells what it calls AI Medical Employees, a set of role based agents covering reception, scribing, coding, nursing intake and triage, interpretation and clinical consultation, integrated with Epic, Oracle Cerner and athenahealth. Ambient documentation is one agent among several rather than the whole product, and the scribe extends past notes into diagnosis identification and care plan suggestion.
Source: AI Health Index, August 2026
Questions buyers ask
How are DeepCura and Sully.ai priced and sold?
For DeepCura, a free trial requires no credit card, cancellation is self service with no fees, and checkout is direct rather than routed through a sales conversation.
With Sully.ai, the vendor states that pricing is customized to clinic size, the number of agents, call or usage volume and the workflows being automated, and that exact pricing is discussed after a demo or pilot conversation. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How much do DeepCura and Sully.ai leave to the clinician?
In DeepCura's case, no agent has a published confidence threshold, accuracy rate, abstention behavior or review gate.
For Sully.ai, the consensus mechanism is a real verification design, agents critiquing one another and scoring proposals before acting, but it is AI checking AI: it reduces single model error without introducing a clinician, so it is not human oversight. The stated destination of a fully autonomous healthcare system makes the disclosure gap more consequential rather than less. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
An earlier version of this comparison said Sully's tiered pricing is reported at a modest per provider rate, and that neither vendor publishes a governance framework. Sully's pricing is customized and published by no tier, so the first rested on third party material and is removed; Sully's trust center lists an AI Governance document behind its access request. Corrected 15 September 2026.
Both platforms take autonomous action well beyond writing a note, drafting orders, codes and patient facing responses, and neither publishes a confidence threshold, an escalation behavior or an accuracy figure for any of it. That is the central gap in this part of the category: the surface expanded faster than the disclosure. Read one phrase carefully on DeepCura, which describes itself in language implying an attestation it has not evidenced; ask for the report and its type. Neither publishes a fairness statement, subgroup analysis or accent and dialect performance. Sully's trust center lists an AI Governance document and AI Software Use Guidance behind its access request, and DeepCura publishes no governance framework; neither publishes governance material a buyer can read without asking. Ask both what proportion of generated orders and codes are edited before they are signed.